0001415889-11-001259.txt : 20111114 0001415889-11-001259.hdr.sgml : 20111111 20111114124908 ACCESSION NUMBER: 0001415889-11-001259 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20111114 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20111114 DATE AS OF CHANGE: 20111114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BOND LABORATORIES, INC. CENTRAL INDEX KEY: 0001374328 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] IRS NUMBER: 000000000 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-52369 FILM NUMBER: 111200062 BUSINESS ADDRESS: STREET 1: 11011 Q STREET BUILDING A STREET 2: SUITE 106 CITY: OMAHA STATE: NE ZIP: 68137 BUSINESS PHONE: 402-884-1894 MAIL ADDRESS: STREET 1: 11011 Q STREET BUILDING A STREET 2: SUITE 106 CITY: OMAHA STATE: NE ZIP: 68137 8-K 1 form8k-11142011_091157.htm Bond Laboratories, Inc. - FORM 8-k



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934

Date of report (Date of earliest event reported):  November 14, 2011

Commission File Number:  000-52369

Bond Laboratories, Inc.
(Exact name of small business issuer as specified in its charter)

Nevada
(State or other jurisdiction of incorporation or organization)
20-3464383
(IRS Employer Identification No.)



11011 Q Street, Building A Suite 106, Omaha, Nebraska 68137
(Address of principal executive offices)

402-333-5260
(Registrant's Telephone number)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)


Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 2.02 Results of Operations and Financial Condition.

On November 14, 2011, Bond Laboratories, Inc. (the "Company") issued a press release highlighting accomplishments, significant revenue growth and positive net income from the Company's recent Form 10-Q. As indicated in the press release, the Company reported $3.2 million in revenue for the quarter ended September 30, 2011, a 58% increase over the $2.0 million for the same period ended September 30, 2010. Bonds Labs also reported year to date revenue and net income of $9.4 million and $782,000, respectively, for the nine month period ended September 30, 2011 as compared to revenue of $6.4 million and a net loss and ($1.5) million for the comparable period last year. A copy of the press release is attached to this Current Report on Form 8-K as Exhibit 99.1.

Item 9.01 Financial Statements and Exhibits.

See Exhibit Index.

SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Bond Laboratories, Inc.


Date:   November 14, 2011
By: /s/ Michael Abrams
Name: Michael Abrams
Title: Chief Financial Officer

Exhibit Index
 
Exhibit No.
   
Description
EX-99.1
   
Press Release November 14, 2011 Earnings
EX-99 2 ex99-11142011_091157.htm Secconnect.com

Bond Labs Reports Profitable 3rd Quarter and YTD Results



OMAHA, Neb.--(BUSINESS WIRE) -- Nov. 14, 2011 -- Bond Laboratories, Inc. (OTCBB:) (“Bond Labs”), a national provider of innovative and proprietary nutritional supplements for health conscious consumers, today announced continued significant revenue growth and positive net income for the third fiscal quarter of 2011. Revenue for the quarter ended September 30, 2011 grew to $3.2 million as compared to $2.0 million for the quarter ended September 30, 2010, an increase of 58%. Bond Labs also reported its third consecutive quarter with positive net income, posting a profit of $291,000 for the quarter ended September 30, 2011 as compared to a net loss of ($560,000) for the same period last year. Year to date, Bonds Labs reported revenue and net income of $9.4 million and $782,000, respectively, for the nine month period ended September 30, 2011 as compared to revenue of $6.4 million and a net loss and ($1.5) million for the comparable period last year.


“We are thrilled to again report both continued, notable revenue growth and positive net income for the third consecutive fiscal quarter. Our year-to date-revenue increased 45%, or almost $3 million, over the comparable period last year. Perhaps even more significant, our year-to-date net income increased almost $2.4 million as compared to our results from the nine months ended September 30, 2010,” commented Bond Labs CEO, John S. Wilson.


“Our growth strategy, which includes increasing the number of GNC franchised outlets selling NDS products and launching new innovative products that create significant value for both Bond Labs and our GNC franchise partners, continues to produce strong results. Over the last twenty-one months, we have increased the number of franchise locations in our distribution system by over 150%, from approximately 320 at the end of 2009 to more than 800 today. In addition to that, we introduced 14 new highly successful and innovative products into GNC’s distribution system. I am truly excited about our prospects, not just for the remainder of the year, but for 2012 and beyond,” concluded Mr. Wilson.


About Bond Labs

Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers. The Company produces and markets products through its NDS Nutrition division. NDS’ products number over 60 brands of energy, sports, and dietary supplements. These products are sold directly through specialty health and nutrition retailers, and are included among the top-selling products at GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit .


Safe Harbor

Statements about the Company’s future expectations and all other statements in this press release other than historical facts, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such forward-looking statements be subject to the safe harbors created thereby. The above information contains information relating to the Company that is based on the beliefs of the Company and/or its management as well as assumptions made by and information currently available to the Company or its management. The company does not undertake any responsibility to update the forward-looking statements contained in this release.


Contact


Surety Financial Group, LLC
Bruce Weinstein

410-833-0078


Source: Bond Laboratories, Inc.